Brainsway (Israel) Performance
| BRIN Stock | 1,775 14.00 0.78% |
The firm shows a Beta (market volatility) of -0.0236, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Brainsway are expected to decrease at a much lower rate. During the bear market, Brainsway is likely to outperform the market. At this point, Brainsway has a negative expected return of -0.1%. Please make sure to confirm Brainsway's market risk adjusted performance, coefficient of variation, jensen alpha, as well as the relationship between the mean deviation and standard deviation , to decide if Brainsway performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Brainsway has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Brainsway |
Brainsway Relative Risk vs. Return Landscape
If you would invest 189,900 in Brainsway on November 29, 2024 and sell it today you would lose (12,400) from holding Brainsway or give up 6.53% of portfolio value over 90 days. Brainsway is generating negative expected returns and assumes 2.5703% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than Brainsway, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Brainsway Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Brainsway's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Brainsway, and traders can use it to determine the average amount a Brainsway's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0398
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BRIN |
Estimated Market Risk
| 2.57 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Brainsway is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Brainsway by adding Brainsway to a well-diversified portfolio.
Brainsway Fundamentals Growth
Brainsway Stock prices reflect investors' perceptions of the future prospects and financial health of Brainsway, and Brainsway fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Brainsway Stock performance.
| EBITDA | (3.89 M) | |||
| Cash And Equivalents | 9.07 M | |||
| Cash Per Share | 0.55 X | |||
| Total Debt | 2.83 M | |||
| Debt To Equity | 40.70 % | |||
| Book Value Per Share | 0.42 X | |||
| Cash Flow From Operations | (3.77 M) | |||
| Earnings Per Share | (0.39) X | |||
| Total Asset | 22 M | |||
| Retained Earnings | (47 M) | |||
| Current Asset | 15 M | |||
| Current Liabilities | 5 M | |||
About Brainsway Performance
By analyzing Brainsway's fundamental ratios, stakeholders can gain valuable insights into Brainsway's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Brainsway has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Brainsway has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. Brainsway Ltd. was founded in 2003 and is based in Jerusalem, Israel. Brainsway Ltd operates under Diagnostics Research classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 96 people.Things to note about Brainsway performance evaluation
Checking the ongoing alerts about Brainsway for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Brainsway help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Brainsway generated a negative expected return over the last 90 days | |
| Brainsway has accumulated about 9.07 M in cash with (3.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55. |
- Analyzing Brainsway's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Brainsway's stock is overvalued or undervalued compared to its peers.
- Examining Brainsway's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Brainsway's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Brainsway's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Brainsway's stock. These opinions can provide insight into Brainsway's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Brainsway Stock analysis
When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |